Furthermore, in a phase 1 clinical trial, [89Zr]Zr-DFO-IAB22M2C was found to accumulate in lymphoid organs and tumour lesions, correlating with infiltration of CD8+ T cells (Figure 5 and Figure 6) [133]. The gene discussed is CD8A; the disease is neoplasm.